nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—ABCB1—hematologic cancer	0.0821	1	CbGaD
Fluphenazine—CYP1A2—Anagrelide—hematologic cancer	0.0355	0.0723	CbGbCtD
Fluphenazine—CYP2E1—Thalidomide—hematologic cancer	0.0227	0.0463	CbGbCtD
Fluphenazine—ABCB1—Lenalidomide—hematologic cancer	0.0215	0.0438	CbGbCtD
Fluphenazine—CYP2E1—Dacarbazine—hematologic cancer	0.0195	0.0398	CbGbCtD
Fluphenazine—CYP2D6—Lomustine—hematologic cancer	0.0188	0.0384	CbGbCtD
Fluphenazine—CYP1A2—Carmustine—hematologic cancer	0.0186	0.038	CbGbCtD
Fluphenazine—CYP2D6—Idarubicin—hematologic cancer	0.0168	0.0342	CbGbCtD
Fluphenazine—CYP1A2—Methoxsalen—hematologic cancer	0.0158	0.0323	CbGbCtD
Fluphenazine—CYP2E1—Mitoxantrone—hematologic cancer	0.0151	0.0309	CbGbCtD
Fluphenazine—CYP1A2—Bortezomib—hematologic cancer	0.0151	0.0307	CbGbCtD
Fluphenazine—CYP1A2—Daunorubicin—hematologic cancer	0.0144	0.0294	CbGbCtD
Fluphenazine—CYP2D6—Hydroxyurea—hematologic cancer	0.0143	0.0291	CbGbCtD
Fluphenazine—CYP1A2—Alitretinoin—hematologic cancer	0.0141	0.0288	CbGbCtD
Fluphenazine—CYP1A2—Thalidomide—hematologic cancer	0.0131	0.0268	CbGbCtD
Fluphenazine—ABCB1—Daunorubicin—hematologic cancer	0.0126	0.0257	CbGbCtD
Fluphenazine—CYP2D6—Bortezomib—hematologic cancer	0.0124	0.0253	CbGbCtD
Fluphenazine—ABCB1—Alitretinoin—hematologic cancer	0.0123	0.0252	CbGbCtD
Fluphenazine—CYP1A2—Dacarbazine—hematologic cancer	0.0113	0.023	CbGbCtD
Fluphenazine—CYP1A2—Imatinib—hematologic cancer	0.011	0.0225	CbGbCtD
Fluphenazine—ABCB1—Imatinib—hematologic cancer	0.00965	0.0197	CbGbCtD
Fluphenazine—CYP2E1—Etoposide—hematologic cancer	0.00955	0.0195	CbGbCtD
Fluphenazine—CYP2D6—Imatinib—hematologic cancer	0.00909	0.0185	CbGbCtD
Fluphenazine—CYP1A2—Dasatinib—hematologic cancer	0.00887	0.0181	CbGbCtD
Fluphenazine—ABCB1—Nilotinib—hematologic cancer	0.00877	0.0179	CbGbCtD
Fluphenazine—ABCB1—Vinorelbine—hematologic cancer	0.0087	0.0177	CbGbCtD
Fluphenazine—CYP2D6—Nilotinib—hematologic cancer	0.00826	0.0169	CbGbCtD
Fluphenazine—CYP2D6—Vinorelbine—hematologic cancer	0.0082	0.0167	CbGbCtD
Fluphenazine—CYP2E1—Dexamethasone—hematologic cancer	0.00785	0.016	CbGbCtD
Fluphenazine—ABCB1—Dasatinib—hematologic cancer	0.00775	0.0158	CbGbCtD
Fluphenazine—ABCB1—Mitoxantrone—hematologic cancer	0.00766	0.0156	CbGbCtD
Fluphenazine—ABCB1—Betamethasone—hematologic cancer	0.00682	0.0139	CbGbCtD
Fluphenazine—ABCB1—Gemcitabine—hematologic cancer	0.00676	0.0138	CbGbCtD
Fluphenazine—ABCB1—Prednisolone—hematologic cancer	0.00673	0.0137	CbGbCtD
Fluphenazine—ABCB1—Prednisone—hematologic cancer	0.00636	0.013	CbGbCtD
Fluphenazine—ABCB1—Irinotecan—hematologic cancer	0.00603	0.0123	CbGbCtD
Fluphenazine—CYP1A2—Etoposide—hematologic cancer	0.00552	0.0113	CbGbCtD
Fluphenazine—ABCB1—Vinblastine—hematologic cancer	0.00536	0.0109	CbGbCtD
Fluphenazine—ABCB1—Vincristine—hematologic cancer	0.00527	0.0107	CbGbCtD
Fluphenazine—CYP2D6—Vinblastine—hematologic cancer	0.00505	0.0103	CbGbCtD
Fluphenazine—ABCB1—Cisplatin—hematologic cancer	0.00491	0.01	CbGbCtD
Fluphenazine—ABCB1—Etoposide—hematologic cancer	0.00483	0.00985	CbGbCtD
Fluphenazine—ABCB1—Dexamethasone—hematologic cancer	0.00397	0.0081	CbGbCtD
Fluphenazine—CYP2D6—Dexamethasone—hematologic cancer	0.00374	0.00763	CbGbCtD
Fluphenazine—ABCB1—Doxorubicin—hematologic cancer	0.00329	0.00672	CbGbCtD
Fluphenazine—ABCB1—Methotrexate—hematologic cancer	0.00319	0.00651	CbGbCtD
Fluphenazine—CYP2D6—Doxorubicin—hematologic cancer	0.0031	0.00633	CbGbCtD
Fluphenazine—HTR1A—hematopoietic system—hematologic cancer	0.000871	0.0359	CbGeAlD
Fluphenazine—CALM2—hematopoietic system—hematologic cancer	0.000856	0.0353	CbGeAlD
Fluphenazine—CALM1—hematopoietic system—hematologic cancer	0.000852	0.0351	CbGeAlD
Fluphenazine—CALM3—blood—hematologic cancer	0.000722	0.0298	CbGeAlD
Fluphenazine—CALM3—bone marrow—hematologic cancer	0.000699	0.0288	CbGeAlD
Fluphenazine—CYP1A2—hematopoietic system—hematologic cancer	0.000664	0.0274	CbGeAlD
Fluphenazine—CALM2—gonad—hematologic cancer	0.000651	0.0268	CbGeAlD
Fluphenazine—CALM1—gonad—hematologic cancer	0.000648	0.0267	CbGeAlD
Fluphenazine—CALM3—lung—hematologic cancer	0.000633	0.0261	CbGeAlD
Fluphenazine—HRH1—hematopoietic system—hematologic cancer	0.000622	0.0256	CbGeAlD
Fluphenazine—ADRA2A—hematopoietic system—hematologic cancer	0.000611	0.0251	CbGeAlD
Fluphenazine—CALM3—testis—hematologic cancer	0.000597	0.0246	CbGeAlD
Fluphenazine—CYP2E1—hematopoietic system—hematologic cancer	0.000597	0.0246	CbGeAlD
Fluphenazine—CALM2—blood—hematologic cancer	0.000567	0.0234	CbGeAlD
Fluphenazine—CALM1—blood—hematologic cancer	0.000565	0.0233	CbGeAlD
Fluphenazine—CALM2—bone marrow—hematologic cancer	0.000549	0.0226	CbGeAlD
Fluphenazine—CALM1—bone marrow—hematologic cancer	0.000546	0.0225	CbGeAlD
Fluphenazine—HTR2A—hematopoietic system—hematologic cancer	0.000519	0.0214	CbGeAlD
Fluphenazine—CALM2—lung—hematologic cancer	0.000497	0.0205	CbGeAlD
Fluphenazine—CALM1—lung—hematologic cancer	0.000495	0.0204	CbGeAlD
Fluphenazine—CYP2D6—hematopoietic system—hematologic cancer	0.000473	0.0195	CbGeAlD
Fluphenazine—CALM2—testis—hematologic cancer	0.000469	0.0193	CbGeAlD
Fluphenazine—CALM1—testis—hematologic cancer	0.000467	0.0192	CbGeAlD
Fluphenazine—ADRA2A—gonad—hematologic cancer	0.000464	0.0191	CbGeAlD
Fluphenazine—DRD2—lung—hematologic cancer	0.000457	0.0188	CbGeAlD
Fluphenazine—CYP1A2—blood—hematologic cancer	0.00044	0.0181	CbGeAlD
Fluphenazine—CALM3—lymph node—hematologic cancer	0.000433	0.0178	CbGeAlD
Fluphenazine—DRD2—testis—hematologic cancer	0.000431	0.0178	CbGeAlD
Fluphenazine—Quetiapine—H1F0—hematologic cancer	0.000419	0.188	CrCbGaD
Fluphenazine—ADRA2A—blood—hematologic cancer	0.000405	0.0167	CbGeAlD
Fluphenazine—CYP2E1—blood—hematologic cancer	0.000396	0.0163	CbGeAlD
Fluphenazine—HTR2A—gonad—hematologic cancer	0.000395	0.0163	CbGeAlD
Fluphenazine—CYP1A2—lung—hematologic cancer	0.000386	0.0159	CbGeAlD
Fluphenazine—HRH1—lung—hematologic cancer	0.000361	0.0149	CbGeAlD
Fluphenazine—ADRA2A—lung—hematologic cancer	0.000355	0.0146	CbGeAlD
Fluphenazine—CYP2E1—lung—hematologic cancer	0.000347	0.0143	CbGeAlD
Fluphenazine—HTR2A—blood—hematologic cancer	0.000344	0.0142	CbGeAlD
Fluphenazine—HRH1—testis—hematologic cancer	0.000341	0.014	CbGeAlD
Fluphenazine—ABCB1—hematopoietic system—hematologic cancer	0.00034	0.014	CbGeAlD
Fluphenazine—CALM2—lymph node—hematologic cancer	0.00034	0.014	CbGeAlD
Fluphenazine—CALM1—lymph node—hematologic cancer	0.000339	0.0139	CbGeAlD
Fluphenazine—ADRA2A—testis—hematologic cancer	0.000335	0.0138	CbGeAlD
Fluphenazine—CYP2E1—testis—hematologic cancer	0.000327	0.0135	CbGeAlD
Fluphenazine—CYP2D6—blood—hematologic cancer	0.000313	0.0129	CbGeAlD
Fluphenazine—HTR2A—lung—hematologic cancer	0.000302	0.0124	CbGeAlD
Fluphenazine—HTR2A—testis—hematologic cancer	0.000284	0.0117	CbGeAlD
Fluphenazine—CYP2D6—testis—hematologic cancer	0.000259	0.0107	CbGeAlD
Fluphenazine—ABCB1—gonad—hematologic cancer	0.000259	0.0107	CbGeAlD
Fluphenazine—HRH1—lymph node—hematologic cancer	0.000247	0.0102	CbGeAlD
Fluphenazine—ADRA2A—lymph node—hematologic cancer	0.000243	0.00999	CbGeAlD
Fluphenazine—Acepromazine—SLC22A1—hematologic cancer	0.000231	0.104	CrCbGaD
Fluphenazine—Thioproperazine—SLC22A1—hematologic cancer	0.000226	0.102	CrCbGaD
Fluphenazine—ABCB1—blood—hematologic cancer	0.000225	0.00928	CbGeAlD
Fluphenazine—Thiothixene—SLC22A1—hematologic cancer	0.000222	0.0999	CrCbGaD
Fluphenazine—Pipotiazine—SLC22A1—hematologic cancer	0.000222	0.0999	CrCbGaD
Fluphenazine—ABCB1—bone marrow—hematologic cancer	0.000218	0.00898	CbGeAlD
Fluphenazine—ABCB1—lung—hematologic cancer	0.000198	0.00814	CbGeAlD
Fluphenazine—ABCB1—testis—hematologic cancer	0.000186	0.00768	CbGeAlD
Fluphenazine—ABCB1—lymph node—hematologic cancer	0.000135	0.00557	CbGeAlD
Fluphenazine—Flupentixol—ABCB1—hematologic cancer	0.000133	0.06	CrCbGaD
Fluphenazine—Chlorpromazine—SLC22A1—hematologic cancer	0.000121	0.0542	CrCbGaD
Fluphenazine—Headache—Vinblastine—hematologic cancer	8.39e-05	0.000383	CcSEcCtD
Fluphenazine—Leukopenia—Etoposide—hematologic cancer	8.38e-05	0.000382	CcSEcCtD
Fluphenazine—Constipation—Alitretinoin—hematologic cancer	8.37e-05	0.000381	CcSEcCtD
Fluphenazine—Hypotension—Gemcitabine—hematologic cancer	8.36e-05	0.000381	CcSEcCtD
Fluphenazine—Anaphylactic shock—Cisplatin—hematologic cancer	8.34e-05	0.00038	CcSEcCtD
Fluphenazine—Hypersensitivity—Bleomycin—hematologic cancer	8.33e-05	0.00038	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Doxorubicin—hematologic cancer	8.33e-05	0.00038	CcSEcCtD
Fluphenazine—Nausea—Cladribine—hematologic cancer	8.3e-05	0.000378	CcSEcCtD
Fluphenazine—Cardiac arrest—Epirubicin—hematologic cancer	8.28e-05	0.000377	CcSEcCtD
Fluphenazine—Constipation—Ifosfamide—hematologic cancer	8.27e-05	0.000377	CcSEcCtD
Fluphenazine—Lethargy—Doxorubicin—hematologic cancer	8.22e-05	0.000375	CcSEcCtD
Fluphenazine—Hypersensitivity—Vinorelbine—hematologic cancer	8.2e-05	0.000374	CcSEcCtD
Fluphenazine—Decreased appetite—Vincristine—hematologic cancer	8.19e-05	0.000374	CcSEcCtD
Fluphenazine—Dyspnoea—Mitoxantrone—hematologic cancer	8.18e-05	0.000373	CcSEcCtD
Fluphenazine—Dyspnoea—Irinotecan—hematologic cancer	8.18e-05	0.000373	CcSEcCtD
Fluphenazine—Urticaria—Thalidomide—hematologic cancer	8.17e-05	0.000372	CcSEcCtD
Fluphenazine—Somnolence—Mitoxantrone—hematologic cancer	8.16e-05	0.000372	CcSEcCtD
Fluphenazine—Somnolence—Irinotecan—hematologic cancer	8.16e-05	0.000372	CcSEcCtD
Fluphenazine—Tachycardia—Cisplatin—hematologic cancer	8.13e-05	0.000371	CcSEcCtD
Fluphenazine—Body temperature increased—Thalidomide—hematologic cancer	8.13e-05	0.000371	CcSEcCtD
Fluphenazine—Skin disorder—Cisplatin—hematologic cancer	8.1e-05	0.000369	CcSEcCtD
Fluphenazine—Hypertension—Etoposide—hematologic cancer	8.08e-05	0.000368	CcSEcCtD
Fluphenazine—Pruritus—Bortezomib—hematologic cancer	8.07e-05	0.000368	CcSEcCtD
Fluphenazine—Constipation—Vincristine—hematologic cancer	8.06e-05	0.000367	CcSEcCtD
Fluphenazine—Asthma—Methotrexate—hematologic cancer	8.04e-05	0.000367	CcSEcCtD
Fluphenazine—Pruritus—Bleomycin—hematologic cancer	8e-05	0.000365	CcSEcCtD
Fluphenazine—Decreased appetite—Irinotecan—hematologic cancer	7.98e-05	0.000364	CcSEcCtD
Fluphenazine—Decreased appetite—Mitoxantrone—hematologic cancer	7.98e-05	0.000364	CcSEcCtD
Fluphenazine—Dyspnoea—Gemcitabine—hematologic cancer	7.97e-05	0.000363	CcSEcCtD
Fluphenazine—Hypertension—Prednisolone—hematologic cancer	7.97e-05	0.000363	CcSEcCtD
Fluphenazine—Eosinophilia—Methotrexate—hematologic cancer	7.96e-05	0.000363	CcSEcCtD
Fluphenazine—Nausea—Vinblastine—hematologic cancer	7.96e-05	0.000363	CcSEcCtD
Fluphenazine—Somnolence—Gemcitabine—hematologic cancer	7.95e-05	0.000362	CcSEcCtD
Fluphenazine—Pruritus—Vinorelbine—hematologic cancer	7.88e-05	0.000359	CcSEcCtD
Fluphenazine—Constipation—Mitoxantrone—hematologic cancer	7.85e-05	0.000358	CcSEcCtD
Fluphenazine—Constipation—Irinotecan—hematologic cancer	7.85e-05	0.000358	CcSEcCtD
Fluphenazine—Hypersensitivity—Thiotepa—hematologic cancer	7.83e-05	0.000357	CcSEcCtD
Fluphenazine—Body temperature increased—Carmustine—hematologic cancer	7.81e-05	0.000356	CcSEcCtD
Fluphenazine—Hypotension—Cisplatin—hematologic cancer	7.79e-05	0.000355	CcSEcCtD
Fluphenazine—Decreased appetite—Gemcitabine—hematologic cancer	7.77e-05	0.000354	CcSEcCtD
Fluphenazine—Urticaria—Alitretinoin—hematologic cancer	7.77e-05	0.000354	CcSEcCtD
Fluphenazine—Headache—Lenalidomide—hematologic cancer	7.76e-05	0.000354	CcSEcCtD
Fluphenazine—Angioedema—Triamcinolone—hematologic cancer	7.75e-05	0.000353	CcSEcCtD
Fluphenazine—Body temperature increased—Alitretinoin—hematologic cancer	7.73e-05	0.000353	CcSEcCtD
Fluphenazine—Erythema—Betamethasone—hematologic cancer	7.7e-05	0.000351	CcSEcCtD
Fluphenazine—Erythema—Dexamethasone—hematologic cancer	7.7e-05	0.000351	CcSEcCtD
Fluphenazine—Urticaria—Ifosfamide—hematologic cancer	7.68e-05	0.00035	CcSEcCtD
Fluphenazine—Cardiac arrest—Doxorubicin—hematologic cancer	7.66e-05	0.000349	CcSEcCtD
Fluphenazine—Headache—Hydroxyurea—hematologic cancer	7.65e-05	0.000349	CcSEcCtD
Fluphenazine—Constipation—Gemcitabine—hematologic cancer	7.65e-05	0.000349	CcSEcCtD
Fluphenazine—Body temperature increased—Ifosfamide—hematologic cancer	7.64e-05	0.000348	CcSEcCtD
Fluphenazine—Pancytopenia—Methotrexate—hematologic cancer	7.64e-05	0.000348	CcSEcCtD
Fluphenazine—Anaphylactic shock—Etoposide—hematologic cancer	7.64e-05	0.000348	CcSEcCtD
Fluphenazine—Hypersensitivity—Thalidomide—hematologic cancer	7.58e-05	0.000345	CcSEcCtD
Fluphenazine—Nausea—Melphalan—hematologic cancer	7.57e-05	0.000345	CcSEcCtD
Fluphenazine—Anaphylactic shock—Prednisolone—hematologic cancer	7.53e-05	0.000343	CcSEcCtD
Fluphenazine—Dysphagia—Epirubicin—hematologic cancer	7.53e-05	0.000343	CcSEcCtD
Fluphenazine—Asthma—Epirubicin—hematologic cancer	7.53e-05	0.000343	CcSEcCtD
Fluphenazine—Pruritus—Thiotepa—hematologic cancer	7.52e-05	0.000343	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Methotrexate—hematologic cancer	7.48e-05	0.000341	CcSEcCtD
Fluphenazine—Nefazodone—ABCB1—hematologic cancer	7.45e-05	0.0335	CrCbGaD
Fluphenazine—Tachycardia—Etoposide—hematologic cancer	7.45e-05	0.00034	CcSEcCtD
Fluphenazine—Eosinophilia—Epirubicin—hematologic cancer	7.45e-05	0.00034	CcSEcCtD
Fluphenazine—Body temperature increased—Vincristine—hematologic cancer	7.45e-05	0.00034	CcSEcCtD
Fluphenazine—Dyspnoea—Cisplatin—hematologic cancer	7.43e-05	0.000339	CcSEcCtD
Fluphenazine—Skin disorder—Etoposide—hematologic cancer	7.42e-05	0.000338	CcSEcCtD
Fluphenazine—Nausea—Lenalidomide—hematologic cancer	7.36e-05	0.000335	CcSEcCtD
Fluphenazine—Tachycardia—Prednisolone—hematologic cancer	7.35e-05	0.000335	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Methotrexate—hematologic cancer	7.34e-05	0.000335	CcSEcCtD
Fluphenazine—Hypertension—Triamcinolone—hematologic cancer	7.33e-05	0.000334	CcSEcCtD
Fluphenazine—Urticaria—Mitoxantrone—hematologic cancer	7.29e-05	0.000332	CcSEcCtD
Fluphenazine—Hypersensitivity—Carmustine—hematologic cancer	7.28e-05	0.000332	CcSEcCtD
Fluphenazine—Pruritus—Thalidomide—hematologic cancer	7.27e-05	0.000332	CcSEcCtD
Fluphenazine—Triflupromazine—ABCB1—hematologic cancer	7.26e-05	0.0326	CrCbGaD
Fluphenazine—Body temperature increased—Mitoxantrone—hematologic cancer	7.26e-05	0.000331	CcSEcCtD
Fluphenazine—Body temperature increased—Irinotecan—hematologic cancer	7.26e-05	0.000331	CcSEcCtD
Fluphenazine—Nausea—Hydroxyurea—hematologic cancer	7.26e-05	0.000331	CcSEcCtD
Fluphenazine—Decreased appetite—Cisplatin—hematologic cancer	7.25e-05	0.00033	CcSEcCtD
Fluphenazine—Pneumonia—Methotrexate—hematologic cancer	7.21e-05	0.000329	CcSEcCtD
Fluphenazine—Hypersensitivity—Alitretinoin—hematologic cancer	7.21e-05	0.000329	CcSEcCtD
Fluphenazine—Drowsiness—Methotrexate—hematologic cancer	7.17e-05	0.000327	CcSEcCtD
Fluphenazine—Pancytopenia—Epirubicin—hematologic cancer	7.15e-05	0.000326	CcSEcCtD
Fluphenazine—Headache—Bortezomib—hematologic cancer	7.14e-05	0.000326	CcSEcCtD
Fluphenazine—Hypotension—Etoposide—hematologic cancer	7.14e-05	0.000325	CcSEcCtD
Fluphenazine—Hypersensitivity—Ifosfamide—hematologic cancer	7.12e-05	0.000325	CcSEcCtD
Fluphenazine—Body temperature increased—Gemcitabine—hematologic cancer	7.07e-05	0.000322	CcSEcCtD
Fluphenazine—Dry mouth—Triamcinolone—hematologic cancer	7.07e-05	0.000322	CcSEcCtD
Fluphenazine—Acepromazine—ALB—hematologic cancer	7.04e-05	0.0317	CrCbGaD
Fluphenazine—Angioedema—Dexamethasone—hematologic cancer	7.04e-05	0.000321	CcSEcCtD
Fluphenazine—Angioedema—Betamethasone—hematologic cancer	7.04e-05	0.000321	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Epirubicin—hematologic cancer	7e-05	0.000319	CcSEcCtD
Fluphenazine—Headache—Vinorelbine—hematologic cancer	6.97e-05	0.000318	CcSEcCtD
Fluphenazine—Dysphagia—Doxorubicin—hematologic cancer	6.96e-05	0.000317	CcSEcCtD
Fluphenazine—Asthma—Doxorubicin—hematologic cancer	6.96e-05	0.000317	CcSEcCtD
Fluphenazine—Hypersensitivity—Vincristine—hematologic cancer	6.95e-05	0.000317	CcSEcCtD
Fluphenazine—Anaphylactic shock—Triamcinolone—hematologic cancer	6.93e-05	0.000316	CcSEcCtD
Fluphenazine—Pruritus—Alitretinoin—hematologic cancer	6.92e-05	0.000315	CcSEcCtD
Fluphenazine—Trazodone—ABCB1—hematologic cancer	6.9e-05	0.031	CrCbGaD
Fluphenazine—Eosinophilia—Doxorubicin—hematologic cancer	6.9e-05	0.000314	CcSEcCtD
Fluphenazine—Thioproperazine—ALB—hematologic cancer	6.88e-05	0.0309	CrCbGaD
Fluphenazine—Photosensitivity reaction—Epirubicin—hematologic cancer	6.87e-05	0.000313	CcSEcCtD
Fluphenazine—Pruritus—Ifosfamide—hematologic cancer	6.84e-05	0.000312	CcSEcCtD
Fluphenazine—Dyspnoea—Etoposide—hematologic cancer	6.81e-05	0.00031	CcSEcCtD
Fluphenazine—Somnolence—Etoposide—hematologic cancer	6.79e-05	0.000309	CcSEcCtD
Fluphenazine—Thiothixene—ALB—hematologic cancer	6.77e-05	0.0304	CrCbGaD
Fluphenazine—Pipotiazine—ALB—hematologic cancer	6.77e-05	0.0304	CrCbGaD
Fluphenazine—Nausea—Bortezomib—hematologic cancer	6.77e-05	0.000309	CcSEcCtD
Fluphenazine—Hypersensitivity—Irinotecan—hematologic cancer	6.76e-05	0.000308	CcSEcCtD
Fluphenazine—Hypersensitivity—Mitoxantrone—hematologic cancer	6.76e-05	0.000308	CcSEcCtD
Fluphenazine—Tachycardia—Triamcinolone—hematologic cancer	6.76e-05	0.000308	CcSEcCtD
Fluphenazine—Pneumonia—Epirubicin—hematologic cancer	6.75e-05	0.000308	CcSEcCtD
Fluphenazine—Nausea—Bleomycin—hematologic cancer	6.72e-05	0.000306	CcSEcCtD
Fluphenazine—Drowsiness—Epirubicin—hematologic cancer	6.71e-05	0.000306	CcSEcCtD
Fluphenazine—Erythema—Prednisone—hematologic cancer	6.71e-05	0.000306	CcSEcCtD
Fluphenazine—Agranulocytosis—Methotrexate—hematologic cancer	6.69e-05	0.000305	CcSEcCtD
Fluphenazine—Headache—Thiotepa—hematologic cancer	6.66e-05	0.000304	CcSEcCtD
Fluphenazine—Hypertension—Betamethasone—hematologic cancer	6.65e-05	0.000303	CcSEcCtD
Fluphenazine—Hypertension—Dexamethasone—hematologic cancer	6.65e-05	0.000303	CcSEcCtD
Fluphenazine—Decreased appetite—Etoposide—hematologic cancer	6.64e-05	0.000303	CcSEcCtD
Fluphenazine—Pancytopenia—Doxorubicin—hematologic cancer	6.61e-05	0.000302	CcSEcCtD
Fluphenazine—Nausea—Vinorelbine—hematologic cancer	6.61e-05	0.000301	CcSEcCtD
Fluphenazine—Body temperature increased—Cisplatin—hematologic cancer	6.59e-05	0.0003	CcSEcCtD
Fluphenazine—Constipation—Etoposide—hematologic cancer	6.53e-05	0.000298	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Doxorubicin—hematologic cancer	6.47e-05	0.000295	CcSEcCtD
Fluphenazine—Headache—Thalidomide—hematologic cancer	6.44e-05	0.000294	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Doxorubicin—hematologic cancer	6.36e-05	0.00029	CcSEcCtD
Fluphenazine—Pruritus—Gemcitabine—hematologic cancer	6.33e-05	0.000288	CcSEcCtD
Fluphenazine—Vision blurred—Prednisone—hematologic cancer	6.32e-05	0.000288	CcSEcCtD
Fluphenazine—Nausea—Thiotepa—hematologic cancer	6.31e-05	0.000288	CcSEcCtD
Fluphenazine—Anaphylactic shock—Dexamethasone—hematologic cancer	6.28e-05	0.000286	CcSEcCtD
Fluphenazine—Anaphylactic shock—Betamethasone—hematologic cancer	6.28e-05	0.000286	CcSEcCtD
Fluphenazine—Agranulocytosis—Epirubicin—hematologic cancer	6.26e-05	0.000286	CcSEcCtD
Fluphenazine—Pneumonia—Doxorubicin—hematologic cancer	6.25e-05	0.000285	CcSEcCtD
Fluphenazine—Drowsiness—Doxorubicin—hematologic cancer	6.21e-05	0.000283	CcSEcCtD
Fluphenazine—Headache—Carmustine—hematologic cancer	6.19e-05	0.000282	CcSEcCtD
Fluphenazine—Dyspnoea—Triamcinolone—hematologic cancer	6.17e-05	0.000281	CcSEcCtD
Fluphenazine—Agitation—Prednisone—hematologic cancer	6.16e-05	0.000281	CcSEcCtD
Fluphenazine—Hypersensitivity—Cisplatin—hematologic cancer	6.14e-05	0.00028	CcSEcCtD
Fluphenazine—Tachycardia—Betamethasone—hematologic cancer	6.13e-05	0.00028	CcSEcCtD
Fluphenazine—Tachycardia—Dexamethasone—hematologic cancer	6.13e-05	0.00028	CcSEcCtD
Fluphenazine—Headache—Alitretinoin—hematologic cancer	6.13e-05	0.000279	CcSEcCtD
Fluphenazine—Angioedema—Prednisone—hematologic cancer	6.13e-05	0.000279	CcSEcCtD
Fluphenazine—Nausea—Thalidomide—hematologic cancer	6.11e-05	0.000278	CcSEcCtD
Fluphenazine—Urticaria—Etoposide—hematologic cancer	6.07e-05	0.000277	CcSEcCtD
Fluphenazine—Body temperature increased—Etoposide—hematologic cancer	6.04e-05	0.000275	CcSEcCtD
Fluphenazine—Urticaria—Prednisolone—hematologic cancer	5.98e-05	0.000273	CcSEcCtD
Fluphenazine—Oedema peripheral—Epirubicin—hematologic cancer	5.94e-05	0.000271	CcSEcCtD
Fluphenazine—Headache—Vincristine—hematologic cancer	5.91e-05	0.000269	CcSEcCtD
Fluphenazine—Hypotension—Dexamethasone—hematologic cancer	5.87e-05	0.000268	CcSEcCtD
Fluphenazine—Hypotension—Betamethasone—hematologic cancer	5.87e-05	0.000268	CcSEcCtD
Fluphenazine—Nausea—Carmustine—hematologic cancer	5.87e-05	0.000267	CcSEcCtD
Fluphenazine—Nausea—Alitretinoin—hematologic cancer	5.81e-05	0.000265	CcSEcCtD
Fluphenazine—Agranulocytosis—Doxorubicin—hematologic cancer	5.8e-05	0.000264	CcSEcCtD
Fluphenazine—Hypertension—Prednisone—hematologic cancer	5.79e-05	0.000264	CcSEcCtD
Fluphenazine—Headache—Mitoxantrone—hematologic cancer	5.75e-05	0.000262	CcSEcCtD
Fluphenazine—Headache—Irinotecan—hematologic cancer	5.75e-05	0.000262	CcSEcCtD
Fluphenazine—Nausea—Ifosfamide—hematologic cancer	5.74e-05	0.000262	CcSEcCtD
Fluphenazine—Hypersensitivity—Etoposide—hematologic cancer	5.63e-05	0.000256	CcSEcCtD
Fluphenazine—Erythema—Methotrexate—hematologic cancer	5.6e-05	0.000255	CcSEcCtD
Fluphenazine—Headache—Gemcitabine—hematologic cancer	5.6e-05	0.000255	CcSEcCtD
Fluphenazine—Nausea—Vincristine—hematologic cancer	5.6e-05	0.000255	CcSEcCtD
Fluphenazine—Hypersensitivity—Prednisolone—hematologic cancer	5.55e-05	0.000253	CcSEcCtD
Fluphenazine—Urticaria—Triamcinolone—hematologic cancer	5.5e-05	0.000251	CcSEcCtD
Fluphenazine—Oedema peripheral—Doxorubicin—hematologic cancer	5.49e-05	0.00025	CcSEcCtD
Fluphenazine—Body temperature increased—Triamcinolone—hematologic cancer	5.48e-05	0.00025	CcSEcCtD
Fluphenazine—Anaphylactic shock—Prednisone—hematologic cancer	5.47e-05	0.000249	CcSEcCtD
Fluphenazine—Decreased appetite—Betamethasone—hematologic cancer	5.46e-05	0.000249	CcSEcCtD
Fluphenazine—Decreased appetite—Dexamethasone—hematologic cancer	5.46e-05	0.000249	CcSEcCtD
Fluphenazine—Nausea—Irinotecan—hematologic cancer	5.45e-05	0.000249	CcSEcCtD
Fluphenazine—Nausea—Mitoxantrone—hematologic cancer	5.45e-05	0.000249	CcSEcCtD
Fluphenazine—Pruritus—Etoposide—hematologic cancer	5.4e-05	0.000246	CcSEcCtD
Fluphenazine—Tachycardia—Prednisone—hematologic cancer	5.34e-05	0.000243	CcSEcCtD
Fluphenazine—Skin disorder—Prednisone—hematologic cancer	5.32e-05	0.000242	CcSEcCtD
Fluphenazine—Nausea—Gemcitabine—hematologic cancer	5.31e-05	0.000242	CcSEcCtD
Fluphenazine—Vision blurred—Methotrexate—hematologic cancer	5.28e-05	0.000241	CcSEcCtD
Fluphenazine—Erythema—Epirubicin—hematologic cancer	5.24e-05	0.000239	CcSEcCtD
Fluphenazine—Hypersensitivity—Triamcinolone—hematologic cancer	5.1e-05	0.000233	CcSEcCtD
Fluphenazine—Muscle spasms—Epirubicin—hematologic cancer	5.04e-05	0.00023	CcSEcCtD
Fluphenazine—Leukopenia—Methotrexate—hematologic cancer	5.02e-05	0.000229	CcSEcCtD
Fluphenazine—Urticaria—Dexamethasone—hematologic cancer	4.99e-05	0.000228	CcSEcCtD
Fluphenazine—Urticaria—Betamethasone—hematologic cancer	4.99e-05	0.000228	CcSEcCtD
Fluphenazine—Body temperature increased—Dexamethasone—hematologic cancer	4.97e-05	0.000226	CcSEcCtD
Fluphenazine—Body temperature increased—Betamethasone—hematologic cancer	4.97e-05	0.000226	CcSEcCtD
Fluphenazine—Nausea—Cisplatin—hematologic cancer	4.95e-05	0.000226	CcSEcCtD
Fluphenazine—Vision blurred—Epirubicin—hematologic cancer	4.94e-05	0.000225	CcSEcCtD
Fluphenazine—Pruritus—Triamcinolone—hematologic cancer	4.9e-05	0.000223	CcSEcCtD
Fluphenazine—Erythema—Doxorubicin—hematologic cancer	4.85e-05	0.000221	CcSEcCtD
Fluphenazine—Agitation—Epirubicin—hematologic cancer	4.82e-05	0.00022	CcSEcCtD
Fluphenazine—Headache—Etoposide—hematologic cancer	4.78e-05	0.000218	CcSEcCtD
Fluphenazine—Decreased appetite—Prednisone—hematologic cancer	4.76e-05	0.000217	CcSEcCtD
Fluphenazine—Headache—Prednisolone—hematologic cancer	4.72e-05	0.000215	CcSEcCtD
Fluphenazine—Leukopenia—Epirubicin—hematologic cancer	4.69e-05	0.000214	CcSEcCtD
Fluphenazine—Constipation—Prednisone—hematologic cancer	4.68e-05	0.000213	CcSEcCtD
Fluphenazine—Muscle spasms—Doxorubicin—hematologic cancer	4.67e-05	0.000213	CcSEcCtD
Fluphenazine—Anaphylactic shock—Methotrexate—hematologic cancer	4.57e-05	0.000209	CcSEcCtD
Fluphenazine—Vision blurred—Doxorubicin—hematologic cancer	4.57e-05	0.000208	CcSEcCtD
Fluphenazine—Nausea—Etoposide—hematologic cancer	4.54e-05	0.000207	CcSEcCtD
Fluphenazine—Hypertension—Epirubicin—hematologic cancer	4.53e-05	0.000206	CcSEcCtD
Fluphenazine—Nausea—Prednisolone—hematologic cancer	4.47e-05	0.000204	CcSEcCtD
Fluphenazine—Trifluoperazine—ABCB1—hematologic cancer	4.47e-05	0.0201	CrCbGaD
Fluphenazine—Agitation—Doxorubicin—hematologic cancer	4.46e-05	0.000203	CcSEcCtD
Fluphenazine—Pruritus—Dexamethasone—hematologic cancer	4.45e-05	0.000203	CcSEcCtD
Fluphenazine—Pruritus—Betamethasone—hematologic cancer	4.45e-05	0.000203	CcSEcCtD
Fluphenazine—Skin disorder—Methotrexate—hematologic cancer	4.44e-05	0.000203	CcSEcCtD
Fluphenazine—Dry mouth—Epirubicin—hematologic cancer	4.37e-05	0.000199	CcSEcCtD
Fluphenazine—Urticaria—Prednisone—hematologic cancer	4.35e-05	0.000198	CcSEcCtD
Fluphenazine—Leukopenia—Doxorubicin—hematologic cancer	4.34e-05	0.000198	CcSEcCtD
Fluphenazine—Headache—Triamcinolone—hematologic cancer	4.34e-05	0.000198	CcSEcCtD
Fluphenazine—Quetiapine—ABCB1—hematologic cancer	4.33e-05	0.0195	CrCbGaD
Fluphenazine—Body temperature increased—Prednisone—hematologic cancer	4.33e-05	0.000197	CcSEcCtD
Fluphenazine—Anaphylactic shock—Epirubicin—hematologic cancer	4.28e-05	0.000195	CcSEcCtD
Fluphenazine—Hypotension—Methotrexate—hematologic cancer	4.27e-05	0.000195	CcSEcCtD
Fluphenazine—Hypertension—Doxorubicin—hematologic cancer	4.19e-05	0.000191	CcSEcCtD
Fluphenazine—Tachycardia—Epirubicin—hematologic cancer	4.18e-05	0.00019	CcSEcCtD
Fluphenazine—Skin disorder—Epirubicin—hematologic cancer	4.16e-05	0.00019	CcSEcCtD
Fluphenazine—Nausea—Triamcinolone—hematologic cancer	4.11e-05	0.000188	CcSEcCtD
Fluphenazine—Dyspnoea—Methotrexate—hematologic cancer	4.08e-05	0.000186	CcSEcCtD
Fluphenazine—Somnolence—Methotrexate—hematologic cancer	4.07e-05	0.000185	CcSEcCtD
Fluphenazine—Dry mouth—Doxorubicin—hematologic cancer	4.04e-05	0.000184	CcSEcCtD
Fluphenazine—Hypersensitivity—Prednisone—hematologic cancer	4.03e-05	0.000184	CcSEcCtD
Fluphenazine—Hypotension—Epirubicin—hematologic cancer	4e-05	0.000182	CcSEcCtD
Fluphenazine—Decreased appetite—Methotrexate—hematologic cancer	3.98e-05	0.000181	CcSEcCtD
Fluphenazine—Anaphylactic shock—Doxorubicin—hematologic cancer	3.96e-05	0.000181	CcSEcCtD
Fluphenazine—Headache—Dexamethasone—hematologic cancer	3.94e-05	0.000179	CcSEcCtD
Fluphenazine—Headache—Betamethasone—hematologic cancer	3.94e-05	0.000179	CcSEcCtD
Fluphenazine—Pruritus—Prednisone—hematologic cancer	3.87e-05	0.000177	CcSEcCtD
Fluphenazine—Tachycardia—Doxorubicin—hematologic cancer	3.87e-05	0.000176	CcSEcCtD
Fluphenazine—Skin disorder—Doxorubicin—hematologic cancer	3.85e-05	0.000175	CcSEcCtD
Fluphenazine—Dyspnoea—Epirubicin—hematologic cancer	3.82e-05	0.000174	CcSEcCtD
Fluphenazine—Somnolence—Epirubicin—hematologic cancer	3.81e-05	0.000173	CcSEcCtD
Fluphenazine—Nausea—Betamethasone—hematologic cancer	3.73e-05	0.00017	CcSEcCtD
Fluphenazine—Nausea—Dexamethasone—hematologic cancer	3.73e-05	0.00017	CcSEcCtD
Fluphenazine—Decreased appetite—Epirubicin—hematologic cancer	3.72e-05	0.00017	CcSEcCtD
Fluphenazine—Hypotension—Doxorubicin—hematologic cancer	3.7e-05	0.000169	CcSEcCtD
Fluphenazine—Chlorpromazine—ALB—hematologic cancer	3.67e-05	0.0165	CrCbGaD
Fluphenazine—Constipation—Epirubicin—hematologic cancer	3.66e-05	0.000167	CcSEcCtD
Fluphenazine—Urticaria—Methotrexate—hematologic cancer	3.63e-05	0.000166	CcSEcCtD
Fluphenazine—Body temperature increased—Methotrexate—hematologic cancer	3.62e-05	0.000165	CcSEcCtD
Fluphenazine—Dyspnoea—Doxorubicin—hematologic cancer	3.53e-05	0.000161	CcSEcCtD
Fluphenazine—Somnolence—Doxorubicin—hematologic cancer	3.52e-05	0.000161	CcSEcCtD
Fluphenazine—Chlorpromazine—ABCB1—hematologic cancer	3.5e-05	0.0157	CrCbGaD
Fluphenazine—Decreased appetite—Doxorubicin—hematologic cancer	3.44e-05	0.000157	CcSEcCtD
Fluphenazine—Headache—Prednisone—hematologic cancer	3.43e-05	0.000156	CcSEcCtD
Fluphenazine—Urticaria—Epirubicin—hematologic cancer	3.4e-05	0.000155	CcSEcCtD
Fluphenazine—Constipation—Doxorubicin—hematologic cancer	3.39e-05	0.000154	CcSEcCtD
Fluphenazine—Body temperature increased—Epirubicin—hematologic cancer	3.38e-05	0.000154	CcSEcCtD
Fluphenazine—Hypersensitivity—Methotrexate—hematologic cancer	3.37e-05	0.000154	CcSEcCtD
Fluphenazine—Nausea—Prednisone—hematologic cancer	3.25e-05	0.000148	CcSEcCtD
Fluphenazine—Pruritus—Methotrexate—hematologic cancer	3.24e-05	0.000148	CcSEcCtD
Fluphenazine—Hypersensitivity—Epirubicin—hematologic cancer	3.15e-05	0.000144	CcSEcCtD
Fluphenazine—Urticaria—Doxorubicin—hematologic cancer	3.15e-05	0.000143	CcSEcCtD
Fluphenazine—Body temperature increased—Doxorubicin—hematologic cancer	3.13e-05	0.000143	CcSEcCtD
Fluphenazine—Pruritus—Epirubicin—hematologic cancer	3.03e-05	0.000138	CcSEcCtD
Fluphenazine—Hypersensitivity—Doxorubicin—hematologic cancer	2.92e-05	0.000133	CcSEcCtD
Fluphenazine—Headache—Methotrexate—hematologic cancer	2.87e-05	0.000131	CcSEcCtD
Fluphenazine—Pruritus—Doxorubicin—hematologic cancer	2.8e-05	0.000128	CcSEcCtD
Fluphenazine—Nausea—Methotrexate—hematologic cancer	2.72e-05	0.000124	CcSEcCtD
Fluphenazine—Headache—Epirubicin—hematologic cancer	2.68e-05	0.000122	CcSEcCtD
Fluphenazine—Nausea—Epirubicin—hematologic cancer	2.54e-05	0.000116	CcSEcCtD
Fluphenazine—Headache—Doxorubicin—hematologic cancer	2.48e-05	0.000113	CcSEcCtD
Fluphenazine—Nausea—Doxorubicin—hematologic cancer	2.35e-05	0.000107	CcSEcCtD
Fluphenazine—ADRA2A—Signaling Pathways—CASP3—hematologic cancer	1.54e-06	8.47e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL2—hematologic cancer	1.54e-06	8.46e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—IL6—hematologic cancer	1.53e-06	8.42e-06	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MYC—hematologic cancer	1.53e-06	8.42e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MTOR—hematologic cancer	1.53e-06	8.4e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PIK3CB—hematologic cancer	1.53e-06	8.4e-06	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PTEN—hematologic cancer	1.53e-06	8.4e-06	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PTEN—hematologic cancer	1.53e-06	8.4e-06	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	1.53e-06	8.4e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—PIK3CA—hematologic cancer	1.52e-06	8.39e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—PIK3CA—hematologic cancer	1.52e-06	8.39e-06	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MYC—hematologic cancer	1.52e-06	8.37e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MDM2—hematologic cancer	1.52e-06	8.36e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MDM2—hematologic cancer	1.52e-06	8.36e-06	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TGFB1—hematologic cancer	1.52e-06	8.35e-06	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—KRAS—hematologic cancer	1.52e-06	8.34e-06	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—KRAS—hematologic cancer	1.52e-06	8.34e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—EP300—hematologic cancer	1.52e-06	8.34e-06	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MYC—hematologic cancer	1.51e-06	8.34e-06	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MYC—hematologic cancer	1.51e-06	8.34e-06	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—EP300—hematologic cancer	1.51e-06	8.34e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—EP300—hematologic cancer	1.51e-06	8.33e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.51e-06	8.32e-06	CbGpPWpGaD
Fluphenazine—CALM2—Disease—TGFB1—hematologic cancer	1.51e-06	8.32e-06	CbGpPWpGaD
Fluphenazine—CALM1—Disease—TGFB1—hematologic cancer	1.51e-06	8.32e-06	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—PIK3CA—hematologic cancer	1.51e-06	8.31e-06	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—EP300—hematologic cancer	1.51e-06	8.28e-06	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.5e-06	8.25e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CCND1—hematologic cancer	1.5e-06	8.25e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—SRC—hematologic cancer	1.5e-06	8.25e-06	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.5e-06	8.24e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—JUN—hematologic cancer	1.5e-06	8.23e-06	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—PIK3CA—hematologic cancer	1.49e-06	8.2e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PIK3CB—hematologic cancer	1.48e-06	8.13e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MTOR—hematologic cancer	1.48e-06	8.13e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MTOR—hematologic cancer	1.48e-06	8.13e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PIK3CB—hematologic cancer	1.48e-06	8.13e-06	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—ALB—hematologic cancer	1.48e-06	8.13e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—SRC—hematologic cancer	1.47e-06	8.11e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—SRC—hematologic cancer	1.47e-06	8.1e-06	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TP53—hematologic cancer	1.46e-06	8.04e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—VEGFA—hematologic cancer	1.46e-06	8.03e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—HRAS—hematologic cancer	1.46e-06	8.02e-06	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—EP300—hematologic cancer	1.46e-06	8.01e-06	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—EP300—hematologic cancer	1.46e-06	8.01e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CDKN1A—hematologic cancer	1.45e-06	7.98e-06	CbGpPWpGaD
Fluphenazine—CALM3—Disease—KRAS—hematologic cancer	1.45e-06	7.96e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PTEN—hematologic cancer	1.45e-06	7.96e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—STAT3—hematologic cancer	1.44e-06	7.95e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.44e-06	7.94e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—NRAS—hematologic cancer	1.44e-06	7.93e-06	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TP53—hematologic cancer	1.44e-06	7.93e-06	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—PIK3CA—hematologic cancer	1.44e-06	7.92e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	1.44e-06	7.9e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CDKN1B—hematologic cancer	1.43e-06	7.89e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	1.43e-06	7.88e-06	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—AKT1—hematologic cancer	1.43e-06	7.88e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—STAT3—hematologic cancer	1.42e-06	7.82e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—STAT3—hematologic cancer	1.42e-06	7.81e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—NRAS—hematologic cancer	1.42e-06	7.81e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—NRAS—hematologic cancer	1.42e-06	7.79e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MAPK8—hematologic cancer	1.41e-06	7.79e-06	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.41e-06	7.78e-06	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—KRAS—hematologic cancer	1.41e-06	7.78e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—AKT1—hematologic cancer	1.41e-06	7.76e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—HRAS—hematologic cancer	1.41e-06	7.76e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—HRAS—hematologic cancer	1.41e-06	7.76e-06	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—KRAS—hematologic cancer	1.41e-06	7.74e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CASP3—hematologic cancer	1.4e-06	7.73e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL2—hematologic cancer	1.4e-06	7.72e-06	CbGpPWpGaD
Fluphenazine—CALM2—Disease—KRAS—hematologic cancer	1.4e-06	7.7e-06	CbGpPWpGaD
Fluphenazine—CALM1—Disease—KRAS—hematologic cancer	1.4e-06	7.7e-06	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—HRAS—hematologic cancer	1.4e-06	7.69e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—IL6—hematologic cancer	1.4e-06	7.68e-06	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—PIK3CA—hematologic cancer	1.39e-06	7.67e-06	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—PIK3CA—hematologic cancer	1.39e-06	7.67e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CDKN1B—hematologic cancer	1.39e-06	7.63e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CDKN1B—hematologic cancer	1.39e-06	7.63e-06	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.38e-06	7.62e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MAPK3—hematologic cancer	1.38e-06	7.6e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—EP300—hematologic cancer	1.38e-06	7.59e-06	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—HRAS—hematologic cancer	1.38e-06	7.58e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCND1—hematologic cancer	1.37e-06	7.52e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—JUN—hematologic cancer	1.36e-06	7.51e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CASP3—hematologic cancer	1.36e-06	7.48e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CASP3—hematologic cancer	1.36e-06	7.48e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	1.36e-06	7.48e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL2—hematologic cancer	1.36e-06	7.47e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL2—hematologic cancer	1.36e-06	7.47e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	1.36e-06	7.46e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—IL6—hematologic cancer	1.35e-06	7.43e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—IL6—hematologic cancer	1.35e-06	7.43e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MYC—hematologic cancer	1.34e-06	7.39e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—SRC—hematologic cancer	1.34e-06	7.38e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TGFB1—hematologic cancer	1.34e-06	7.37e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.34e-06	7.36e-06	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IL6—hematologic cancer	1.34e-06	7.36e-06	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—HRAS—hematologic cancer	1.33e-06	7.33e-06	CbGpPWpGaD
Fluphenazine—CALM3—Disease—PIK3CA—hematologic cancer	1.33e-06	7.32e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CDKN1A—hematologic cancer	1.32e-06	7.28e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCND1—hematologic cancer	1.32e-06	7.28e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCND1—hematologic cancer	1.32e-06	7.28e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MYC—hematologic cancer	1.32e-06	7.27e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—JUN—hematologic cancer	1.32e-06	7.26e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—JUN—hematologic cancer	1.32e-06	7.26e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PTEN—hematologic cancer	1.32e-06	7.26e-06	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IL6—hematologic cancer	1.32e-06	7.26e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MYC—hematologic cancer	1.32e-06	7.25e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	1.32e-06	7.25e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	1.31e-06	7.24e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—VEGFA—hematologic cancer	1.31e-06	7.19e-06	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.3e-06	7.18e-06	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	1.3e-06	7.14e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—STAT3—hematologic cancer	1.29e-06	7.12e-06	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—PIK3CA—hematologic cancer	1.29e-06	7.11e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MAPK8—hematologic cancer	1.29e-06	7.1e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—NRAS—hematologic cancer	1.29e-06	7.1e-06	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—HRAS—hematologic cancer	1.29e-06	7.09e-06	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—HRAS—hematologic cancer	1.29e-06	7.09e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—AKT1—hematologic cancer	1.29e-06	7.08e-06	CbGpPWpGaD
Fluphenazine—CALM2—Disease—PIK3CA—hematologic cancer	1.29e-06	7.08e-06	CbGpPWpGaD
Fluphenazine—CALM1—Disease—PIK3CA—hematologic cancer	1.29e-06	7.08e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CDKN1A—hematologic cancer	1.28e-06	7.04e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CDKN1A—hematologic cancer	1.28e-06	7.04e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PTEN—hematologic cancer	1.28e-06	7.03e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PTEN—hematologic cancer	1.28e-06	7.03e-06	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL6—hematologic cancer	1.27e-06	7.02e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.27e-06	6.98e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—EP300—hematologic cancer	1.26e-06	6.93e-06	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TP53—hematologic cancer	1.26e-06	6.91e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—ALB—hematologic cancer	1.25e-06	6.89e-06	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TP53—hematologic cancer	1.25e-06	6.88e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MAPK8—hematologic cancer	1.25e-06	6.87e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MAPK8—hematologic cancer	1.25e-06	6.87e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—AKT1—hematologic cancer	1.25e-06	6.85e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—AKT1—hematologic cancer	1.25e-06	6.85e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—KRAS—hematologic cancer	1.24e-06	6.83e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MAPK3—hematologic cancer	1.24e-06	6.8e-06	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL6—hematologic cancer	1.23e-06	6.79e-06	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL6—hematologic cancer	1.23e-06	6.79e-06	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—AKT1—hematologic cancer	1.23e-06	6.79e-06	CbGpPWpGaD
Fluphenazine—CALM3—Disease—HRAS—hematologic cancer	1.23e-06	6.77e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—SRC—hematologic cancer	1.22e-06	6.73e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—KRAS—hematologic cancer	1.22e-06	6.72e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PIK3CA—hematologic cancer	1.22e-06	6.72e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—KRAS—hematologic cancer	1.22e-06	6.7e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—EP300—hematologic cancer	1.22e-06	6.7e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—EP300—hematologic cancer	1.22e-06	6.7e-06	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—AKT1—hematologic cancer	1.22e-06	6.7e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MYC—hematologic cancer	1.2e-06	6.61e-06	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—HRAS—hematologic cancer	1.2e-06	6.61e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TGFB1—hematologic cancer	1.2e-06	6.6e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.2e-06	6.59e-06	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PTEN—hematologic cancer	1.2e-06	6.58e-06	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—HRAS—hematologic cancer	1.19e-06	6.58e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—VEGFA—hematologic cancer	1.19e-06	6.56e-06	CbGpPWpGaD
Fluphenazine—CALM2—Disease—HRAS—hematologic cancer	1.19e-06	6.55e-06	CbGpPWpGaD
Fluphenazine—CALM1—Disease—HRAS—hematologic cancer	1.19e-06	6.55e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—SRC—hematologic cancer	1.18e-06	6.51e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—SRC—hematologic cancer	1.18e-06	6.51e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—STAT3—hematologic cancer	1.18e-06	6.49e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NRAS—hematologic cancer	1.18e-06	6.48e-06	CbGpPWpGaD
Fluphenazine—CALM3—Disease—IL6—hematologic cancer	1.18e-06	6.48e-06	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—AKT1—hematologic cancer	1.18e-06	6.47e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—VEGFA—hematologic cancer	1.15e-06	6.35e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—VEGFA—hematologic cancer	1.15e-06	6.35e-06	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IL6—hematologic cancer	1.15e-06	6.33e-06	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IL6—hematologic cancer	1.14e-06	6.29e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—STAT3—hematologic cancer	1.14e-06	6.28e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—STAT3—hematologic cancer	1.14e-06	6.28e-06	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—EP300—hematologic cancer	1.14e-06	6.28e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	1.14e-06	6.27e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NRAS—hematologic cancer	1.14e-06	6.27e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NRAS—hematologic cancer	1.14e-06	6.27e-06	CbGpPWpGaD
Fluphenazine—CALM2—Disease—IL6—hematologic cancer	1.14e-06	6.27e-06	CbGpPWpGaD
Fluphenazine—CALM1—Disease—IL6—hematologic cancer	1.14e-06	6.27e-06	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—AKT1—hematologic cancer	1.14e-06	6.26e-06	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—AKT1—hematologic cancer	1.14e-06	6.26e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MAPK3—hematologic cancer	1.13e-06	6.21e-06	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.13e-06	6.2e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	1.12e-06	6.17e-06	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.12e-06	6.17e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	1.12e-06	6.16e-06	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PIK3CA—hematologic cancer	1.11e-06	6.13e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—KRAS—hematologic cancer	1.11e-06	6.11e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.1e-06	6.08e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TP53—hematologic cancer	1.1e-06	6.07e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MYC—hematologic cancer	1.1e-06	6.04e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TGFB1—hematologic cancer	1.09e-06	6.02e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MAPK3—hematologic cancer	1.09e-06	6e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MAPK3—hematologic cancer	1.09e-06	6e-06	CbGpPWpGaD
Fluphenazine—CALM3—Disease—AKT1—hematologic cancer	1.09e-06	5.98e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TP53—hematologic cancer	1.08e-06	5.97e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TP53—hematologic cancer	1.08e-06	5.96e-06	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PIK3CA—hematologic cancer	1.08e-06	5.93e-06	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PIK3CA—hematologic cancer	1.08e-06	5.93e-06	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—EP300—hematologic cancer	1.07e-06	5.92e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MYC—hematologic cancer	1.06e-06	5.84e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MYC—hematologic cancer	1.06e-06	5.84e-06	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—AKT1—hematologic cancer	1.06e-06	5.84e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TGFB1—hematologic cancer	1.06e-06	5.82e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TGFB1—hematologic cancer	1.06e-06	5.82e-06	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—AKT1—hematologic cancer	1.05e-06	5.81e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—HRAS—hematologic cancer	1.05e-06	5.8e-06	CbGpPWpGaD
Fluphenazine—CALM1—Disease—AKT1—hematologic cancer	1.05e-06	5.78e-06	CbGpPWpGaD
Fluphenazine—CALM2—Disease—AKT1—hematologic cancer	1.05e-06	5.78e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—HRAS—hematologic cancer	1.04e-06	5.71e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—HRAS—hematologic cancer	1.04e-06	5.7e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PIK3CA—hematologic cancer	1.02e-06	5.61e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—KRAS—hematologic cancer	1.01e-06	5.58e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IL6—hematologic cancer	1.01e-06	5.55e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—AKT1—hematologic cancer	9.97e-07	5.49e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IL6—hematologic cancer	9.93e-07	5.47e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IL6—hematologic cancer	9.91e-07	5.45e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TP53—hematologic cancer	9.87e-07	5.43e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—KRAS—hematologic cancer	9.8e-07	5.39e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—KRAS—hematologic cancer	9.8e-07	5.39e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PTEN—hematologic cancer	9.55e-07	5.25e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—HRAS—hematologic cancer	9.44e-07	5.19e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—AKT1—hematologic cancer	9.31e-07	5.12e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PIK3CA—hematologic cancer	9.31e-07	5.12e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—AKT1—hematologic cancer	9.16e-07	5.04e-06	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—AKT1—hematologic cancer	9.15e-07	5.04e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—AKT1—hematologic cancer	9.14e-07	5.03e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—EP300—hematologic cancer	9.11e-07	5.01e-06	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—AKT1—hematologic cancer	9.09e-07	5.01e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL6—hematologic cancer	9.03e-07	4.97e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TP53—hematologic cancer	9.01e-07	4.96e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PIK3CA—hematologic cancer	9.01e-07	4.96e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PIK3CA—hematologic cancer	9.01e-07	4.96e-06	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—AKT1—hematologic cancer	8.8e-07	4.84e-06	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—AKT1—hematologic cancer	8.8e-07	4.84e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TP53—hematologic cancer	8.71e-07	4.79e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TP53—hematologic cancer	8.71e-07	4.79e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—HRAS—hematologic cancer	8.61e-07	4.74e-06	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PIK3CA—hematologic cancer	8.44e-07	4.64e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—AKT1—hematologic cancer	8.33e-07	4.59e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—HRAS—hematologic cancer	8.33e-07	4.59e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—HRAS—hematologic cancer	8.33e-07	4.59e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL6—hematologic cancer	8.24e-07	4.54e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL6—hematologic cancer	7.97e-07	4.39e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL6—hematologic cancer	7.97e-07	4.39e-06	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	7.95e-07	4.38e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—AKT1—hematologic cancer	7.6e-07	4.19e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—AKT1—hematologic cancer	7.36e-07	4.05e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—AKT1—hematologic cancer	7.36e-07	4.05e-06	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—AKT1—hematologic cancer	6.89e-07	3.79e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	6.74e-07	3.71e-06	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—AKT1—hematologic cancer	6.5e-07	3.57e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—AKT1—hematologic cancer	5.5e-07	3.03e-06	CbGpPWpGaD
